Impact of in-hospital cardiac rehabilitation on mortality and readmissions in heart failure: A population study in Lombardy, Italy, from 2005 to 2012

European Journal of Preventive Cardiology
Simonetta ScalviniMaria Frigerio

Abstract

The 2016 European guidelines for the diagnosis and treatment of heart failure classified cardiac rehabilitation as a mandatory class I intervention. We aimed to analyse in heart failure patients the impact of an in-hospital cardiac rehabilitation programme on all-cause mortality and readmissions. From the Lombardy healthcare administrative database, we analysed in patients with incident heart failure, from 2005 to 2012, the number of all hospitalisations, cardiac rehabilitation admissions, post-discharge deaths, outpatient drug prescriptions and visits. We divided patients into hospitalised for heart failure in acute care only (group A) versus patients with one or more admission to cardiac rehabilitation for an in-hospital cardiac rehabilitation programme (group B). Of 140,552 incident cases, 100,843 (71%) were in group A and 39,709 (29%) in group B. Patients in group B had 3.26 ± 1.78 admissions to acute care before referral to an in-hospital cardiac rehabilitation programme. Male gender, age in women and comorbidities (more than two) were higher in group B ( P < 0.0001). Patients in group B had a higher number of interventional procedures ( P < 0.0001), drug prescription and outpatient visit rate ( P < 0.0001). Total mortalit...Continue Reading

References

Aug 5, 2005·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ugo CorràUNKNOWN Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Christopher M O'ConnorUNKNOWN HF-ACTION Investigators
Jun 27, 2009·Journal of the American College of Cardiology·Jose A SuayaDonald S Shepard
Jan 7, 2011·Journal of Clinical Epidemiology·Joshua J GagneSebastian Schneeweiss
Jul 30, 2011·Journal of the American College of Cardiology·Jill Downing, Gary J Balady
Aug 30, 2012·Medical Care·Mansour T A SharabianiAlex Bottle
Dec 12, 2012·European Journal of Internal Medicine·Jiri ParenicaUNKNOWN AHEAD Main investigators
Mar 12, 2013·Circulation. Heart Failure·Luigi TavazziUNKNOWN IN-HF (Italian Network on Heart Failure) Outcome Investigators
Mar 30, 2013·European Journal of Heart Failure·Aldo P MaggioniUNKNOWN Heart Failure Association of the European Society of Cardiology (HFA)
Jun 28, 2013·Journal of Cardiopulmonary Rehabilitation and Prevention·Carl J LavieRoss Arena
Nov 20, 2013·Journal of Epidemiology and Community Health·Natalie Gavrielov-Yusim, Michael Friger
Dec 3, 2014·International Journal of Cardiology·L J Anderson, R S Taylor
Feb 11, 2015·Nature Reviews. Cardiology·Stephen J GreeneMihai Gheorghiade
May 29, 2015·European Journal of Heart Failure·Giuseppe Di TanoUNKNOWN IN-HF Outcome Investigators
Jun 20, 2015·Journal of the American College of Cardiology·Daniel E FormanUNKNOWN American College of Cardiology’s Prevention of Cardiovascular Disease Section
Sep 21, 2015·International Journal of Cardiology·Jindrich SpinarJiri Parenica
Nov 11, 2015·Annals of Family Medicine·Isabelle Vedel, Vladimir Khanassov
Jun 6, 2016·European Journal of Internal Medicine·Domenico ScrutinioMaria Frigerio
Sep 8, 2016·European Journal of Preventive Cardiology·Massimo F PiepoliAntonio Pelliccia
Mar 21, 2017·Trends in Cardiovascular Medicine·Sean R McMahonPaul D Thompson
Aug 2, 2017·European Journal of Preventive Cardiology·Alison PoffleyAdrienne O'Neil

❮ Previous
Next ❯

Citations

Jan 25, 2020·Expert Review of Medical Devices·Simonetta ScalviniPalmira Bernocchi
Jul 2, 2020·European Journal of Preventive Cardiology·Karsten KellerPhilip Wenzel
Mar 28, 2020·European Journal of Preventive Cardiology·Faye Forsyth, Christi Deaton
Nov 27, 2020·European Journal of Preventive Cardiology·Stefania PaolilloJeness Campodonico
Feb 22, 2021·European Journal of Preventive Cardiology·Faye Forsyth, Christi Deaton
Jun 6, 2021·European Journal of Preventive Cardiology·Geza Halasz, Massimo F Piepoli
Aug 18, 2021·European Journal of Preventive Cardiology·Karsten KellerPhilip Wenzel
Aug 24, 2021·Frontiers in Cardiovascular Medicine·Andrea PassantinoMaria Teresa La Rovere
Nov 7, 2021·Archives of Physical Medicine and Rehabilitation·Domenico ScrutinioMaria Teresa La Rovere

❮ Previous
Next ❯

Methods Mentioned

BETA
percutaneous transluminal coronary angioplasty

Software Mentioned

. table
R
data
ExTraMATCH

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.